Roger Foo

Biochemistry, Genetics and Molecular Biology · Life Sciences

59h-index12.2kcitations431works8.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(36), Hormonal Regulation and Hypertension(35), RNA modifications and cancer(29), Congenital heart defects research(29), Cardiac Fibrosis and Remodeling(24)

Publications430 total

Building Digital Twins of Different Human Organs for Personalized Healthcare
ArXiv.org·2026Open Access
Building Digital Twins of Different Human Organs for Personalized Healthcare
arXiv (Cornell University)·2026Open Access
Deep learning representations and proteome-wide Mendelian randomization identify causal mediators of myocardial fibrosis
2025Open Access
The “silent gap”: Geographic and socioeconomic disparities in Singapore’s cardiometabolic screening
Annals of the Academy of Medicine Singapore·2025Open Access
E. coli (16S and 23S) and S. cerevisiae (18S and 25S) rRNA benchmark dataset: Samples 1 – 5
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
E. coli (16S and 23S) and S. cerevisiae (18S and 25S) rRNA benchmark dataset: Samples 6 – 10
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
Author response for "Impact of quantity and source of dietary protein intake within a healthy dietary pattern on cardiovascular disease risk factors in Singapore older adults: A randomized controlled trial"
2025
Author response for "Impact of quantity and source of dietary protein intake within a healthy dietary pattern on cardiovascular disease risk factors in Singapore older adults: A randomized controlled trial"
2025
Healthcare workers’ knowledge, attitudes, and practices towards cardiovascular disease prevention: a multi-national cross-sectional study
Postgraduate Medical Journal·2025
CTCF Mediates the Cis-Regulatory Hubs in Mouse Hearts
International Journal of Molecular Sciences·2025Open Access
MON-296 Tissue Sodium Content For Differential Diagnosis Of Essential Hypertension Versushyperaldosteronism: Baseline Characteristics Of The “See-Sodium-To-Treat (SSTT)” Trial
Journal of the Endocrine Society·2025Open Access
SAT-282 Renin-Independent Hyperaldosteronism Associated With Increased Risk of Hypertension and Metabolic Syndrome in a Multi-Ethnic Asian Cohort
Journal of the Endocrine Society·2025Open Access
ASTHMA MEDICATION AND FACTORS AFFECTING ADHERENCE: A SCOPING REVIEW
CHEST Journal·2025Open Access
Chromatin landscape and enhancer-gene interaction differences between three cardiac cell types
2025Open Access
Transcriptional regulation in heart development, disease and regeneration: reassessing the fetal gene hypothesis
Nature Reviews Cardiology·2025
Waist circumference remains the better predictor of insulin resistance compared to 2025 Lancet Commission definition on clinical obesity
Diabetes Obesity and Metabolism·2025· 2 cited
LIPTER, a cardiomyocyte-enriched long noncoding RNA, controls cardiac cytoskeletal maturation and is regulated by a cardiomyocyte-specific enhancer
2025Open Access
Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial
Nature Communications·2025· 5 citedOpen Access
Targeting RUNX1 in Macrophages Facilitates Cardiac Recovery
2025Open Access
Lipoprotein(a) as a predictor of mortality in hospitalised patients with ischaemic heart disease
Frontiers in Endocrinology·2025Open Access
page 1 of 22Next →

Frequent Co-authors

Wilson Lek Wen Tan(11), Nicholas Chew(8), Mark Muthiah(8), Mark Y. Chan(7), Matthew Ackers‐Johnson(7), Cheng Han Ng(6), Yip Han Chin(6), Gwyneth Kong(5), Gemma A. Figtree(5), Bryan Chong(5), Mark Richards(5), Mehregan Movassagh(5), Martin R. Bennett(5), Chukwuemeka George Anene-Nzelu(5), Zenia Tiang(5), Tuan Danh Anh Luu(5), Jiong‐Wei Wang(4), Georgios K. Dimitriadis(4), Arun J. Sanyal(4), Mamas A. Mamas(4)